Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
about
Methotrexate for giant cell arteritisAspirin as adjunctive treatment for giant cell arteritisAspirin as adjunctive treatment for giant cell arteritisInflammatory diseases of the aortaThe role of biological agents in the management of large vessel vasculitis (LVV): a systematic review and meta-analysisClinical practice. Giant-cell arteritis and polymyalgia rheumaticaGiant Cell Arteritis and Polymyalgia Rheumatica: 2016 UpdateGastrointestinal aspects of vasculitides.Update on the management of giant cell arteritis.Giant cell arteritis: a review.Th17 and Th1 T-cell responses in giant cell arteritis.Estimating the Cost of Illness of Giant Cell Arteritis in the United States.[Current "off label use" of methotrexate for chronic inflammatory rheumatic diseases].Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.The treatment of giant cell arteritisAn unusual cause of bilateral ophthalmoplegia.Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement.Giant cell arteritis: Current treatment and management.Disease Relapses among Patients with Giant Cell Arteritis: A Prospective, Longitudinal Cohort Study.Relapses in patients with giant cell arteritis: prevalence, characteristics, and associated clinical findings in a longitudinally followed cohort of 106 patientsGiant cell arteritis: a multicenter observational study in Brazil.Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda.The diagnosis and treatment of giant cell arteritis.Steroid-sparing effect and toxicity of dapsone treatment in giant cell arteritis: A single-center, retrospective study of 70 patients.Translational mini-review series on immunology of vascular disease: accelerated atherosclerosis in vasculitis.Pharmacotherapy of vasculitis.An approach to the diagnosis and management of systemic vasculitis.Update on the use of biologics in primary systemic vasculitides.Current understanding and management of giant cell arteritis and polymyalgia rheumatica.New indications for biological therapies.Polymyalgia rheumatica and giant cell arteritis: an in-depth look at diagnosis and treatment.Headache and temporal arteritis: when to suspect and how to manage.Clinical features of polymyalgia rheumatica and giant cell arteritis.Tocilizumab: a new therapy for large vessel vasculitis.Clinical diagnosis and management of large vessel vasculitis: giant cell arteritis.Methotrexate: an old new drug in autoimmune disease.Giant cell arteritis and polymyalgia rheumatica: an update.Giant Cell Arteritis: Beyond Corticosteroids.New insights into the pathogenesis of giant cell arteritis and hopes for the clinic.Diagnosis, Management, and Outcome of Aortitis at a Single Center.
P2860
Q24185826-3636FF77-DC55-4941-AA7B-64D58300FA1CQ24194497-DA6F26F8-1B35-4232-ABAD-9CACC390D6BBQ24198176-C150826E-9177-40DB-95EE-0DB0B4F87B30Q26740223-B82AEAD8-136D-458E-B2E9-991593A7B593Q26853258-422FE658-6B8B-4D4A-9ADC-61E2D42DBFA7Q27005821-C954A32B-4052-4182-BC14-EBA140BF261BQ28070137-B189C29F-210F-48A8-9FF8-160B356BDF26Q30240787-87B2B9EE-B5EC-4844-A38F-5A126AE566A6Q33605954-E9934AD3-B4BE-41B3-8B4F-F010909D357CQ33688189-9F9C058F-524A-493B-AFC8-98B3DBDAAD42Q33723160-AA32E276-46B6-4C32-818B-DEB52E62BB45Q33725515-12998BAD-EEBE-4C27-9C69-899C582E54A4Q34160848-20E6092F-0ED0-4CED-AD11-F753DD793BBEQ34205665-64918839-F727-46C6-8ECF-272309BDEF83Q34461224-277C470B-8B5A-440C-B56E-2BBA33E4591EQ34535692-78E95FF9-C537-4694-8CF6-EAF522CBB223Q35094621-F2D71161-EF5A-4DE6-9685-FE034E2BCFDFQ35746677-E94ED87E-14F6-4F1D-87AF-B19D442C9386Q35861674-2B15F232-EF3C-4E6A-BB36-D118CB0FA569Q36150929-F5D9B997-0794-4A0C-8926-FEFC841DCB75Q36727516-70DB040F-4EA3-44D6-9E1A-A72C29723ECFQ36843077-5B5CB923-8AB7-4A90-A166-D77C5124C47CQ36921249-B714A6FE-491B-45AD-8918-8D94D1B51E5BQ37364920-D7E8E7A5-9328-4ADD-9078-0B6E461478F5Q37421814-80ED1485-C158-4BB3-8AFB-AEADC1C76604Q37483910-D3C79CDC-05D0-4D75-9AFB-1A7CE7DCD478Q37673239-129D4621-F4C1-47A7-BA1B-12C69457DD94Q37754811-E0EB049A-1A05-4964-926D-82778D814313Q37803414-7855918B-A2D1-4946-BEE6-6CD9DC482F0DQ37947157-D4B6867D-A4FA-4807-9A49-39F2288D1D0AQ38007012-C2025A89-1D18-4DAB-85F0-E225056CA5BDQ38007105-8FEDA608-DEAD-44B7-96DA-A2A0700DD5E1Q38028863-19F14424-FE85-4F2F-BE38-F416D8DC0B6DQ38129269-C34B303E-C8AA-456C-98DF-0AAEDD113972Q38217341-512242FA-8E25-4F07-AC7C-3EE747DD87CAQ38253237-7AF02D2D-D56E-41D1-B76C-26BEE70599DAQ38331238-66493DE2-7EA4-45B2-80C3-C6EC0F7A408BQ38560322-02B873C0-F76A-461E-BCB1-655398C87886Q38586408-50878398-E78B-4966-BD85-3F55B65D59B7Q38599488-573FBE66-E05B-47B8-853F-1A3F54A27B1C
P2860
Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Adjunctive methotrexate for tr ...... al patient data meta-analysis.
@ast
Adjunctive methotrexate for tr ...... al patient data meta-analysis.
@en
type
label
Adjunctive methotrexate for tr ...... al patient data meta-analysis.
@ast
Adjunctive methotrexate for tr ...... al patient data meta-analysis.
@en
prefLabel
Adjunctive methotrexate for tr ...... al patient data meta-analysis.
@ast
Adjunctive methotrexate for tr ...... al patient data meta-analysis.
@en
P2093
P2860
P356
P1476
Adjunctive methotrexate for tr ...... al patient data meta-analysis.
@en
P2093
Benjamin Fernández-Gutiérrez
César Hernández-García
Juan A Jover
Peter A Merkel
Robert F Spiera
P2860
P304
P356
10.1002/ART.22754
P577
2007-08-01T00:00:00Z